First Time Loading...
Search stocks here...
Dashboard Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator
Pricing About Contact Us
Sign Up Log in

ESSA Pharma Inc
NASDAQ:EPIX

Watchlist Manager
ESSA Pharma Inc Logo
ESSA Pharma Inc
NASDAQ:EPIX
Watchlist
Price: 3 USD +2.39% Market Closed
Updated: Jun 1, 2023
EPIX
/
Profitability
/
Net Margin

Net Margin

According to ESSA Pharma Inc's latest financial reports the company's net margin is 0%.

0%
Current
0%
Average
-6.4%
Industry
What is Net Margin?

Net Margin History

Statistics
Net Margin

1 Year 3 Years 5 Years
Average 0% 0% 0%
Median 0% 0% 0%
Min 0% 0% 0%
Max 0% 0% 0%

History Chart
Net Margin

Net Margin Distribution

Net Margin Distribution
Biotechnology Industry

Net Margin Across Competitors

Net Margin Comparison
ESSA Pharma Inc Competitors

Country Company Market Cap Net
Margin
CA
ESSA Pharma Inc
NASDAQ:EPIX
132M USD N/A
US
Abbvie Inc
NYSE:ABBV
243B USD
13%
US
Amgen Inc
NASDAQ:AMGN
118B USD
30%
AU
CSL Ltd
ASX:CSL
148B AUD
18%
US
Gilead Sciences Inc
NASDAQ:GILD
96B USD
21%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
83.3B USD
35%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
80.7B USD
34%
US
Moderna Inc
NASDAQ:MRNA
49B USD
32%
US
Biogen Inc
NASDAQ:BIIB
42.9B USD
31%
US
Seagen Inc
NASDAQ:SGEN
36.7B USD
-32%
DK
Genmab A/S
NASDAQ:GMAB
25.9B USD
34%
ESSA Pharma Inc
NASDAQ:EPIX
Country CA
Market Cap 132M USD
Net Margin N/A
Abbvie Inc
NYSE:ABBV
Country US
Market Cap 243B USD
Net Margin
13%
Amgen Inc
NASDAQ:AMGN
Country US
Market Cap 118B USD
Net Margin
30%
CSL Ltd
ASX:CSL
Country AU
Market Cap 148B AUD
Net Margin
18%
Gilead Sciences Inc
NASDAQ:GILD
Country US
Market Cap 96B USD
Net Margin
21%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Country US
Market Cap 83.3B USD
Net Margin
35%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Country US
Market Cap 80.7B USD
Net Margin
34%
Moderna Inc
NASDAQ:MRNA
Country US
Market Cap 49B USD
Net Margin
32%
Biogen Inc
NASDAQ:BIIB
Country US
Market Cap 42.9B USD
Net Margin
31%
Seagen Inc
NASDAQ:SGEN
Country US
Market Cap 36.7B USD
Net Margin
-32%
Genmab A/S
NASDAQ:GMAB
Country DK
Market Cap 25.9B USD
Net Margin
34%

Profitability Report

View the profitability report to see the full profitability analysis for ESSA Pharma Inc.

Full Profitability Report

See Also

Summary
EPIX intrinsic value, competitors valuation, and company profile.
DCF Valuation
EPIX stock valuation using Discount Cash Flow valuation method.
Relative Valuation
EPIX stock valuation using valuation multiples.
Wall Street Estimates
EPIX price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
EPIX stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Similar Stocks
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received.

Net margin helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
=
Net Income
/
Revenue
ALPHA SPREAD
Join more than 54,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Pricing Terms of Service Privacy Policy Affiliate Program

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2023 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.